Medicinal Products

Blincyto

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Blincyto
Active Substance blinatumomab
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L01XC19
Medicinal product marketed in the Croatia Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Educational materials
for healthcare professionals
Vodič za liječnike, verzija 3
Vodič za ljekarnike, verzija 3
Vodič za medicinske sestre, verzija 3
Educational materials
for patients / caregivers
Vodič za bolesnike i njegovatelje, verzija 3
Kartica za bolesnika, verzija 3
Back